Until today, patients with diabetes who need insulin to manage their disease has only one way to treat their condition.
The FDA is committed to sharing emerging drug information with the public and we believe it is important to share with health care providers and patients the latest serious reports of infection associated with this drug that we have received,
Today's approval is a major step forward in making breakthrough treatments available for patients with rare and difficult to treat forms of cancer.
We consider this approval an important advance in the treatment of head and neck cancer because it has been shown to help some patients live longer. Patients need as many effective treatment options as possible.